Brainstorm Cell Therapeutics | BCLI - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Biogen USD 3.38B 374.2M 2026-03
Brainstorm Cell Therapeutics USD 5K 819K 2025-09
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Cytokinetics USD 129.84M 7.32M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Mesoblast USD 129.57M 31.58M 2025-12